Exclusive

 

Exclusive - Mahindras exploring aviation foray

Jul 23 2015

The aviation authorities are awaiting a formal proposal from Mahindras including details of promoters for the new airline

Exclusive - New bar-coding rule may crimp pharma margins

Jul 21 2015

Health Ministry is planning a "Track-and-Trace" mechanism via bar-coding to check proliferation of spurious and counterfeit drugs but it may raise cost.

Modi's solar mission brings down cost to new low of Rs 5/unit

Jul 15 2015

Canadian major SkyPower bid Rs 5.05-5.29/unit for three solar projects in Madhya Pradesh.

Exclusive - Need legislative backing for skill development

Jul 15 2015

While PM Narendra Modi was launching the Skill India initiative, states need to be on board for legislation.

Exclusive - Bitter pill for pharma firms over clinical trials

Jul 13 2015

The Drugs and Cosmetics Bill may tighten clinical trials rules with steep penalties and even jail term for erring officials.

Indian Markets

 
  • SENSEX

    34,543.28 73.36   (-0.21 %)
  • NIFTY

    10,587.25 27.10   (-0.26 %)
sensex-box-shadowimg

Global Markets

 

Stocks In News

 

ZENSAR TECH Q4

Revenue up 9.5% at Rs 814 Cr vs Rs 743 Cr

EBIT up 79% at Rs 82 Cr vs Rs 45.8 Cr

EBIT margin at 10% vs 6.1%

Net Profit up 6.9x at Rs 74 Cr vs Rs 10.7 Cr

Other Income at Rs 26.7 Cr vs Loss of Rs 22.8 Cr

All figures are consolidated and comparable QoQ

PERSISTENT TECH Q4

Net Sales up 19% at Rs 344 Cr vs Rs 289 Cr

EBITDA up 15.7% at Rs 191 Cr vs Rs 165 Cr

EBTDA Margin at 55.5% vs 57%

Net Profit up 40.5% at Rs 142 Cr vs Rs 101 Cr

All figures are Consolidated & comparable YoY

OBEROI REALTY Q4

Net Sales up 19% at Rs 344 Cr vs Rs 289 Cr

EBITDA up 15.7% at Rs 191 Cr vs Rs 165 Cr

EBTDA Margin at 55.5% vs 57%

Net Profit up 40.5% at Rs 142 Cr vs Rs 101 Cr

All figures are Consolidated & comparable YoY

GIC HSG FINANCE Q4

PAT At Rs 60 Cr vs Rs 46.6 Cr, Up 28.8% YoY

NII at Rs 109 cr vs Rs 100 cr, up 9%

Revenue From Ops At Rs 296 Cr Vs Rs 266 Cr, Up 11.3% YoY

IDFC BANK Q4

PAT Rs 41.9 Cr vs Rs 176 Cr, Down 76% YoY

NII At Rs 453 Cr vs Rs 502 Cr, Down 10% YoY

Gross NPA At 3.31% vs 5.62% QoQ;

Net NPA At 1.69% vs 2.52% QoQ

Provisions At Rs 242 Cr vs Rs 108.6 Cr , up 2.2x QoQ

RAYMOND Q4

Revenue Rs 1,655 Cr vs Rs 1,506 Cr, Up 10% YoY

EBITDA Rs 176 Cr vs Rs 145 Cr, Up 21% YoY

EBITDA Margin 10.6% vs 9.6% YoY

PAT Rs 53 Cr vs Rs 33 Cr, Up 60% YoY

All Figures Are Consolidated

twitter @BTVI